139 related articles for article (PubMed ID: 9722315)
1. IgG from patients with antiphospholipid syndrome binds to platelets without induction of platelet activation.
Ford I; Urbaniak S; Greaves M
Br J Haematol; 1998 Aug; 102(3):841-9. PubMed ID: 9722315
[TBL] [Abstract][Full Text] [Related]
2. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation in patients with antiphospholipid syndrome.
Shechter Y; Tal Y; Greenberg A; Brenner B
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):653-7. PubMed ID: 9863715
[TBL] [Abstract][Full Text] [Related]
4. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation.
Bontadi A; Ruffatti A; Giannini S; Falcinelli E; Tonello M; Hoxha A; Gresele P; Punzi L
Reumatismo; 2012 Mar; 64(1):35-9. PubMed ID: 22472781
[TBL] [Abstract][Full Text] [Related]
6. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin.
Vega-Ostertag M; Harris EN; Pierangeli SS
Arthritis Rheum; 2004 Sep; 50(9):2911-9. PubMed ID: 15457460
[TBL] [Abstract][Full Text] [Related]
7. Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies.
Billoir P; Miranda S; Damian L; Richard V; Benhamou Y; Le Cam Duchez V
Thromb Res; 2018 Sep; 169():87-92. PubMed ID: 30031291
[TBL] [Abstract][Full Text] [Related]
8. Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
Barbati C; Stefanini L; Colasanti T; Cipriano E; Celia A; Gabriele G; Vomero M; Ceccarelli F; Spinelli FR; Finucci A; Speziali M; Orso G; Margiotta DPE; Conti F; Violi F; Afeltra A; Valesini G; Alessandri C
Arthritis Res Ther; 2019 Jul; 21(1):161. PubMed ID: 31262358
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies.
Fanelli A; Bergamini C; Rapi S; Caldini A; Spinelli A; Buggiani A; Emmi L
Lupus; 1997; 6(3):261-7. PubMed ID: 9104734
[TBL] [Abstract][Full Text] [Related]
10. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis.
Joseph JE; Harrison P; Mackie IJ; Isenberg DA; Machin SJ
Br J Haematol; 2001 Nov; 115(2):451-9. PubMed ID: 11703349
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibody-dependent C5b-9 formation.
Stewart MW; Etches WS; Gordon PA
Br J Haematol; 1997 Mar; 96(3):451-7. PubMed ID: 9054647
[TBL] [Abstract][Full Text] [Related]
12. C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets.
Skoglund C; Wetterö J; Tengvall P; Bengtsson T
Immunobiology; 2010 Dec; 215(12):987-95. PubMed ID: 20163886
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation and turnover in the primary antiphospholipid syndrome.
Joseph JE; Donohoe S; Harrison P; Mackie IJ; Machin SJ
Lupus; 1998; 7(5):333-40. PubMed ID: 9696137
[TBL] [Abstract][Full Text] [Related]
14. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
[TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes on platelet activation in different manifestations of atherosclerosis.
Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
Swiss Med Wkly; 2013; 143():w13800. PubMed ID: 23740526
[TBL] [Abstract][Full Text] [Related]
16. The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.
Terrisse AD; Laurent PA; Garcia C; Gratacap MP; Vanhaesebroeck B; Sié P; Payrastre B
Thromb Haemost; 2016 Jun; 115(6):1138-46. PubMed ID: 26818901
[TBL] [Abstract][Full Text] [Related]
17. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
18. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Lackner KJ; von Landenberg C; Barlage S; Schmitz G
Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
[TBL] [Abstract][Full Text] [Related]
19. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
